Post-partum Anemia treatment with injectable Iron preperatio
Not Applicable
- Conditions
- Health Condition 1: D509- Iron deficiency anemia, unspecifiedHealth Condition 2: null- Post Partum Patient
- Registration Number
- CTRI/2018/08/015366
- Lead Sponsor
- Deptt Of OBGY
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Post Partum Patient suffering from Iron Deficiency Anemia irrespective of mode of delivery
Exclusion Criteria
Patient in shock
Patient in shock
Patient with Liver disorders
Patient with anemia other than Iron deficiency anemia
Patient with CVS disorder
Patient with histoy of allergy to parenteral iron
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the efficacy of IV FCM and IV IS in the treatment of post-partum IDA. <br/ ><br>Efficacy of treatment will be determined by rate of improvement in-: <br/ ><br> Hb <br/ ><br> Mean Corpuscular Volume (MCV) <br/ ><br> Mean Corpuscular Hemoglobin (MCH) <br/ ><br>Mean Corpuscular Hemoglobin Concentration (MCHC) <br/ ><br>Reticulocyte count <br/ ><br>Timepoint: 4 week after treatment
- Secondary Outcome Measures
Name Time Method Side effect profile <br/ ><br>Injection site thrombophlebitis <br/ ><br>Nausea <br/ ><br>Vomiting <br/ ><br>Fever <br/ ><br>Arthralgia <br/ ><br>Headache <br/ ><br>Hypotension <br/ ><br>Hypertension <br/ ><br>Anaphylactic reaction <br/ ><br>Need for blood transfusion <br/ ><br>Congestive Cardiac failure <br/ ><br>Sub-involution of uterus <br/ ><br>Lactation Failure <br/ ><br>Post-partum hemorrhage <br/ ><br>Puerperal sepsis <br/ ><br>Thromboembolic episode <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: 4 week after treatment